TiumBio Statistics

Total Valuation

TiumBio has a market cap or net worth of KRW 87.08 billion. The enterprise value is 78.13 billion.

Market Cap	87.08B
Enterprise Value	78.13B

Important Dates

The last earnings date was Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

TiumBio has 26.71 million shares outstanding. The number of shares has increased by 5.88% in one year.

Current Share Class	n/a
Shares Outstanding	26.71M
Shares Change (YoY)	+5.88%
Shares Change (QoQ)	-1.08%
Owned by Insiders (%)	32.27%
Owned by Institutions (%)	0.34%
Float	13.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.40
PB Ratio	1.70
P/TBV Ratio	1.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.78
EV / Sales	11.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.69

Financial Position

The company has a current ratio of 2.15, with a Debt / Equity ratio of 0.48.

Current Ratio	2.15
Quick Ratio	1.89
Debt / Equity	0.48
Debt / EBITDA	n/a
Debt / FCF	-1.81
Interest Coverage	-4.62

Financial Efficiency

Return on equity (ROE) is -32.75% and return on invested capital (ROIC) is -11.52%.

Return on Equity (ROE)	-32.75%
Return on Assets (ROA)	-10.30%
Return on Invested Capital (ROIC)	-11.52%
Return on Capital Employed (ROCE)	-23.42%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.41% in the last 52 weeks. The beta is 0.68, so TiumBio's price volatility has been lower than the market average.

Beta (5Y)	0.68
52-Week Price Change	-59.41%
50-Day Moving Average	3,459.60
200-Day Moving Average	5,098.35
Relative Strength Index (RSI)	43.65
Average Volume (20 Days)	76,694

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TiumBio had revenue of KRW 6.79 billion and -20.64 billion in losses. Loss per share was -799.00.

Revenue	6.79B
Gross Profit	6.79B
Operating Income	-18.70B
Pretax Income	-23.55B
Net Income	-20.64B
EBITDA	-14.90B
EBIT	-18.70B
Loss Per Share	-799.00

Full Income Statement

Balance Sheet

The company has 50.62 billion in cash and 30.18 billion in debt, giving a net cash position of 20.44 billion or 765.36 per share.

Cash & Cash Equivalents	50.62B
Total Debt	30.18B
Net Cash	20.44B
Net Cash Per Share	765.36
Equity (Book Value)	62.64B
Book Value Per Share	1,914.60
Working Capital	31.45B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -15.63 billion and capital expenditures -1.04 billion, giving a free cash flow of -16.67 billion.

Operating Cash Flow	-15.63B
Capital Expenditures	-1.04B
Free Cash Flow	-16.67B
FCF Per Share	-623.99

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-275.30%
Pretax Margin	-346.67%
Profit Margin	n/a
EBITDA Margin	-219.38%
EBIT Margin	-275.30%
FCF Margin	n/a

Dividends & Yields

TiumBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.88%
Shareholder Yield	-5.88%
Earnings Yield	-23.71%
FCF Yield	-19.14%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TiumBio has an Altman Z-Score of 0.27. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.27
Piotroski F-Score	n/a